CORTICOBASAL SYNDROME (CBS)
Clinical trials for CORTICOBASAL SYNDROME (CBS) explained in plain language.
Never miss a new study
Get alerted when new CORTICOBASAL SYNDROME (CBS) trials appear
Sign up with your email to follow new studies for CORTICOBASAL SYNDROME (CBS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common drug slow down this rare brain disease?
Disease control OngoingThis phase 2 trial tests whether glycerol phenylbutyrate (GPB) can slow corticobasal syndrome (CBS), a rare and fast-progressing brain disease. 32 adults with CBS will receive either GPB or a placebo for 26 weeks. The main goal is to see if GPB lowers levels of a nerve damage mar…
Matched conditions: CORTICOBASAL SYNDROME (CBS)
Phase: PHASE2 • Sponsor: Technical University of Munich • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New study probes brain inflammation to unlock dementia mysteries
Knowledge-focused OngoingThis observational study looks at how brain inflammation contributes to frontotemporal lobar degeneration (FTLD), a group of disorders that cause dementia. Researchers will use advanced brain scans, blood tests, and spinal fluid analysis in 110 participants to find biomarkers tha…
Matched conditions: CORTICOBASAL SYNDROME (CBS)
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:38 UTC